Regulatory T-cell differentiation and their function in immune regulation

Advances in Experimental Medicine and Biology

Volumn 841, Issue , 2014, Pages 67-97

  Piccioni, Miranda ^a   Chen, Zuojia ^a   Tsun, Andy ^a,b   Li, Bin ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b Innovent Biologics   (China)

Author keywords

Characteristics; Development; Function; Treg

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYCLIC AMP; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 23; LONG UNTRANSLATED RNA; MICRORNA; PROTEIN KINASE B; RECOMBINANT INTERLEUKIN 21; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR REL; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; FOXP3 GENE; GITR GENE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IMMUNOTHERAPY; INDUCED REGULATORY T LYMPHOCYTE; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; NATURAL REGULATORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; THYMUS; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 84922534424     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-94-017-9487-9_4     Document Type: Article

References (231)

1. Adeegbe D, Matsutani T et al (2010) CD4(+) CD25(+) Foxp3(+) T regulatory cells with limited TCR diversity in control of autoimmunity. J Immunol 184(1):56-66
2. Akdis CA, Blaser K (2001) Mechanisms of interleukin-10-mediated immune suppression. Immunology 103(2):131-136
3. Allan SE, Crome SQ et al (2007) Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19(4):345-354
4. Apostolou I, von Boehmer H (2004) In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199(10):1401-1408
5. Arpaia NC, Campbell et al. (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 7480:451-455
6. Atarashi K, Tanoue T et al (2011) Induction of colonic regulatory T-cells by indigenous Clostridium species. Science 331(6015):337-341
7. Atarashi K, Tanoue T et al (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500(7461):232-236
8. Bacchetta R, Lucarelli B et al (2014) Immunological Outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T Cells. Front Immunol 5:16
9. Bagavant H, Tung KS (2005) Failure of CD25+ T-cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis. J Immunol 175(2):944-950
10. Banerjee A, Vasanthakumar A et al (2013) Modulating T regulatory cells in cancer: how close are we? Immunol Cell Biol 91(5):340-349
11. Barath S, Aleksza M et al (2007) Measurement of natural (CD4+ CD25high) and inducible (CD4+ IL-10+) regulatory T-cells in patients with systemic lupus erythematosus. Lupus 16(7):489-496
12. Barnes MJ, Krebs P et al (2009) Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol 7(3):e51
13. Baron U, Floess S et al (2007) DNA demethylation in the human FOXP3 locus discriminates regulatory T-cells from activated FOXP3(+) conventional T cells. Eur J Immunol 37(9):2378-2389
14. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215-233
15. Battaglia M, Stabilini A et al (2006) Rapamycin promotes expansion of functional CD4 +CD25+FOXP3+ regulatory T-cells of both healthy subjects and type 1 diabetic patients. J Immunol 177(12):8338-8347
16. Bazhin AV, Kahnert S et al (2010) Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells. Mol Immunol 47(4):678-684
17. Bedner P, Niessen H et al (2006) Selective permeability of different connexin channels to the second messenger cyclic AMP. J Biol Chem 281(10):6673-6681
18. Beebe AM, Cua DJ et al (2002) The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13(4-5):403-412
19. Bennett CL, Christie J et al (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27(1):20-21
20. Bettelli E, Das MP et al (1998) IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 161(7):3299-3306
21. Bilate AM, Lafaille JJ (2012) Induced CD4+Foxp3+ regulatory T-cells in immune tolerance. Annu Rev Immunol 30:733-758
22. Bodor J, Feigenbaum L et al (2001) Suppression of T-cell responsiveness by inducible cAMP early repressor (ICER). J Leukoc Biol 69(6):1053-1059
23. Bopp T, Becker C et al (2007) Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 204(6):1303-1310
24. Brunstein CG, Miller JS et al (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117(3): 1061-1070
25. Brusko T, Wasserfall C et al (2007) No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 56(3):604-612
26. Burzyn D, Benoist C et al (2013) Regulatory T-cells in nonlymphoid tissues. Nat Immunol 14(10):1007-1013
27. Burzyn D, Kuswanto W et al (2013) A special population of regulatory T-cells potentiates muscle repair. Cell 155(6):1282-1295
28. Cebula A, Seweryn M et al (2013) Thymus-derived regulatory T-cells contribute to tolerance to commensal microbiota. Nature 497(7448):258-262
29. Chambers CA, Kuhns MS et al (2001) CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol 19:565-594
30. Chatila TA, Blaeser F et al (2000) JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106(12):R75-R81
31. Chaudhry A, Rudra D et al (2009) CD4+ regulatory T-cells control TH17 responses in a Stat3-dependent manner. Science 326(5955):986-991
32. Chen W, Jin W et al (2003) Conversion of peripheral CD4+CD25− naive T-cells to CD4 +CD25+ regulatory T-cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198(12):1875-1886
33. Cho JH, Gregersen PK (2011) Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 365(17):1612-1623
34. Chong MM, Rasmussen JP et al (2008) The RNAseIII enzyme Drosha is critical in T-cells for preventing lethal inflammatory disease. J Exp Med 205(9):2005-2017
35. Chung Y, Tanaka S et al (2011) Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med 17(8):983-988
36. Cipolletta D, Feuerer M et al (2012) PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486(7404):549-553
37. Collison LW, Workman CJ et al (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450(7169):566-569
38. Collison LW, Chaturvedi V et al (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11(12):1093-1101
39. Crispin JC, Liossis SN et al (2010) Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med 16(2):47-57
40. Curiel TJ, Coukos G et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10(9):942-949
41. Curotto de Lafaille MA, Lino AC et al (2004) CD25− T cells generate CD25+Foxp3 + regulatory T cells by peripheral expansion. J Immunol 173(12):7259-7268
42. Curotto de Lafaille MA, Kutchukhidze N et al (2008) Adaptive Foxp3+ regulatory T celldependent and -independent control of allergic inflammation. Immunity 29(1):114-126
43. Curti A, Pandolfi S et al (2007) Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25− into CD25+ T regulatory cells. Blood 109 (7):2871-2877
44. Datto MB, Frederick JP et al (1999) Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol Cell Biol 19(4): 2495-2504
45. Deaglio S, Dwyer KM et al (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204(6):1257-1265
46. Demir L, Yigit S et al (2013) Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs. Clin Exp Metastasis 30(8):1047-1062
47. Di Ianni M, Falzetti F et al (2011) Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117(14):3921-3928
48. Duhen T, Duhen R et al (2012) Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 119(19):4430-4440
49. Elkord E (2009) Frequency of human T regulatory cells in peripheral blood is significantly reduced by cryopreservation. J Immunol Methods 347(1-2):87-90
50. Etemire E, Krull M et al (2013) Transiently reduced PI3 K/Akt activity drives the development of regulatory function in antigen-stimulated Naive T-cells. PLoS ONE 8(7): e68378
51. Fallarino F, Grohmann U et al (2006) The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 176(11):6752-6761
52. Fantini MC, Becker C et al (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25− T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172(9):5149-5153
53. Feuerer M, Herrero L et al (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15(8):930-939
54. Feuerer M, Hill JA et al (2009) Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 10(7):689-695
55. Floess S, Freyer J et al (2007) Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 5(2):e38
56. Fohse L, Suffner J et al (2011) High TCR diversity ensures optimal function and homeostasis of Foxp3+ regulatory T cells. Eur J Immunol 41(11):3101-3113
57. Fontenot JD, Gavin MA et al (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4(4):330-336
58. Fontenot JD, Rasmussen JP et al (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6(11):1142-1151
59. Friedlander MR, Lizano E et al (2014) Evidence for the biogenesis of more than 1,000 novel human microRNAs. Genome Biol 15(4):R57
60. Furtado GC, Curotto de Lafaille MA et al (2002) Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J Exp Med 196(6):851-857
61. Furusawa Y, Obata Y et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504(7480):446-450
62. Gagliani N, Magnani CF et al (2013) Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med 19(6):739-746
63. Gavin MA, Torgerson TR et al (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 103(17):6659-6664
64. Gazzinelli RT, Wysocka M et al (1996) In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4 + T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 157(2):798-805
65. Glisic-Milosavljevic S, Waukau J et al (2007) At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction. PLoS ONE 2(1):e146
66. Gobert M, Treilleux I et al (2009) Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res 69(5):2000-2009
67. Goerner M, Gooley T et al (2002) Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biol Blood Marrow Transplant 8(1):47-56
68. Gottschalk RA, Corse E et al (2010) TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J Exp Med 207(8):1701-1711
69. Govindaraj C, Scalzo-Inguanti K et al (2013) Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment. Clin Immunol 149(1):97-110
70. Grohmann U, Fallarino F et al (2003) Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 24(5):242-248
71. Grohmann U, Volpi C et al (2007) Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 13(5):579-586
72. Groux H, O’Garra A et al (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389(6652):737-742
73. Guo H, Ingolia NT et al (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466(7308):835-840
74. Gupta S, Manicassamy S et al (2008) Differential requirement of PKC-theta in the development and function of natural regulatory T cells. Mol Immunol 46(2):213-224
75. Hata H, Sakaguchi N et al (2004) Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114(4):582-588
76. Hayashi T, Hasegawa K et al (2005) Elimination of CD4(+)CD25(+) T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB × NZW F mice. Int J Exp Pathol 86(5):289-296
77. Herman AE, Freeman GJ et al (2004) CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med 199(11):1479-1489
78. Hindley JP, Ferreira C et al (2011) Analysis of the T-cell receptor repertoires of tumorinfiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors. Cancer Res 71(3):736-746
79. Hinterberger M, Aichinger M et al (2010) Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance. Nat Immunol 11(6):512-519
80. Hoffmann P, Boeld TJ et al (2006) Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol Blood Marrow Transplant 12(3):267-274
81. Hori S, Haury M et al (2002) Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci USA 99(12):8213-8218
82. Hori S, Nomura T et al (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609):1057-1061
83. Hsieh CS, Liang Y et al (2004) Recognition of the peripheral self by naturally arising CD25 +CD4+ T cell receptors. Immunity 21(2):267-277
84. Hsu WT, Suen JL et al (2006) The role of CD4CD25 T cells in autoantibody production in murine lupus. Clin Exp Immunol 145(3):513-519
85. Hsu LY, Tan YX et al (2009) A hypomorphic allele of ZAP-70 reveals a distinct thymic threshold for autoimmune disease versus autoimmune reactivity. J Exp Med 206 (11):2527-2541
86. Hung T, Wang Y et al (2011) Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 43(7):621-629
87. Isomura I, Palmer S et al (2009) c-Rel is required for the development of thymic Foxp3+CD4 regulatory T cells. J Exp Med 206(13):3001-3014
88. Itoh M, Takahashi T et al (1999) Thymus and autoimmunity: production of CD25+CD4 + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162(9):5317-5326
89. Jailwala P, Waukau J et al (2009) Apoptosis of CD4+CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation. PLoS ONE 4(8):e6527
90. Jordan MS, Boesteanu A et al (2001) Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2(4):301-306
91. Kerdiles YM, Stone EL et al (2010) Foxo transcription factors control regulatory T cell development and function. Immunity 33(6):890-904
92. Khalil AM, Guttman M et al (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 106(28):11667-11672
93. Khattri R, Cox T et al (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4(4):337-342
94. Kim HP, Leonard WJ (2007) CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 204(7):1543-1551
95. Kim JM, Rasmussen JP et al (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8(2):191-197
96. Kitani A, Fuss I et al (2003) Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis. J Exp Med 198(8):1179-1188
97. Koch MA, Tucker-Heard G et al (2009) The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10(6):595-602
98. Koonpaew S, Shen S et al (2006) LAT-mediated signaling in CD4+CD25+ regulatory T cell development. J Exp Med 203(1):119-129
99. Kornete M, Sgouroudis E et al (2012) ICOS-dependent homeostasis and function of Foxp3 + regulatory T cells in islets of nonobese diabetic mice. J Immunol 188(3):1064-1074
100. Kretschmer K, Apostolou I et al (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6(12):1219-1227
101. Ladoire S, Martin F et al (2011) Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother 60 (7):909-918
102. Lahl K, Loddenkemper C et al (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204(1):57-63
103. Lathrop SK, Bloom SM et al (2011) Peripheral education of the immune system by colonic commensal microbiota. Nature 478(7368):250-254
104. Laurie KL, Van Driel IR et al (2002) The role of CD4+CD25+ immunoregulatory T cells in the induction of autoimmune gastritis. Immunol Cell Biol 80(6):567-573
105. Leon LR, Kozak W et al (1998) Role of IL-10 in inflammation. Studies using cytokine knockout mice. Ann N Y Acad Sci 856:69-75
106. Liao G, Nayak S et al (2010) GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells. Int Immunol 22(4):259-270
107. Lin SC, Chen KH et al (2007) The quantitative analysis of peripheral blood FOXP3- expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 37(12):987-996
108. Lin SZ, Chen KJ et al (2013) Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells. Cancer Prev Res (Phila) 6(6):594-602
109. Linterman MA, Pierson W et al (2011) Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med 17(8):975-982
110. Lio CW, Dodson LF et al (2010) CD28 facilitates the generation of Foxp3(-) cytokine responsive regulatory T cell precursors. J Immunol 184(11):6007-6013
111. Liston A, Lu LF et al (2008) Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205(9):1993-2004
112. Liu W, Putnam AL et al (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203(7):1701-1711
113. Liu VC, Wong LY et al (2007) Tumor evasion of the immune system by converting CD4 +CD25− T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol 178(5):2883-2892
114. Liu X, Robinson SN et al (2014) FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells. Bone Marrow Transplant 49(6):793-799
115. Loewer S, Cabili MN et al (2010) Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 42(12):1113-1117
116. Lu LF, Thai TH et al (2009) Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30(1):80-91
117. Lu LF, Boldin MP et al (2010) Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142(6):914-929
118. Lu L, Ma J et al (2011) All-trans retinoic acid promotes TGF-beta-induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus. PLoS ONE 6(9):e24590
119. Lyssuk EY, Torgashina AV et al (2007) Reduced number and function of CD4+CD25 high FoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 601:113-119
120. Macfarlane GT, Macfarlane S (1997) Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl 222:3-9
121. Makita S, Kanai T et al (2007) Intestinal lamina propria retaining CD4+CD25+ regulatory T cells is a suppressive site of intestinal inflammation. J Immunol 178(8):4937-4946
122. Mantel PY, Ouaked N et al (2006) Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 176(6):3593-3602
123. Marek-Trzonkowska N, Mysliwiec M et al (2012) Administration of CD4+CD25 high CD127- regulatory T cells preserves beta-cell function in type 1 diabetes in children. Diabetes Care 35(9):1817-1820
124. Marks SD, Tullus K (2012) Autoantibodies in systemic lupus erythematosus. Pediatr Nephrol 27(10):1855-1868
125. Marson A, Kretschmer K et al (2007) Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445(7130):931-935
126. McHugh RS, Whitters MJ et al (2002) CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16(2):311-323
127. Mestecky J, McGhee JR (1987) Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 40:153-245
128. Miyara M, Amoura Z et al (2005) Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 175(12):8392-8400
129. Miyara M, Yoshioka Y et al (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30(6):899-911
130. Mucida D, Kutchukhidze N et al (2005) Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 115(7):1923-1933
131. Nakamura K, Kitani A et al (2001) Cell contact-dependent immunosuppression by CD4(+) CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194(5):629-644
132. Nakamura K, Kitani A et al (2004) TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 172(2):834-842
133. Nelson BH, Willerford DM (1998) Biology of the interleukin-2 receptor. Adv Immunol 70:1-81
134. Nguyen LT, Jacobs J et al (2007) Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 56(2):509-520
135. Ohkura N, Hamaguchi M et al (2012) T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37(5):785-799
136. Olivares-Villagomez D, Wang Y et al (1998) Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med 188(10):1883-1894
137. Onishi Y, Fehervari Z et al (2008) Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci USA 105(29):10113-10118
138. Onizuka S, Tawara I et al (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59(13):3128-3133
139. Ostman S, Rask C et al (2006) Impaired regulatory T cell function in germ-free mice. Eur J Immunol 36(9):2336-2346
140. Ouyang W, Beckett O et al (2010) Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol 11(7):618-627
141. Ouyang W, Liao W et al (2012) Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature 491(7425):554-559
142. Pacholczyk R, Kern J (2008) The T-cell receptor repertoire of regulatory T cells. Immunology 125(4):450-458
143. Pacholczyk R, Ignatowicz H et al (2006) Origin and T cell receptor diversity of Foxp3+CD4 +CD25+ T cells. Immunity 25(2):249-259
144. Pandiyan P, Zheng L et al (2007) CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 8(12):1353-1362
145. Pandiyan P, Conti HR et al (2011) CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 34(3):422-434
146. Papiernik M (2001) Natural CD4+CD25+ regulatory T cells. Their role in the control of superantigen responses. Immunol Rev 182:180-189
147. Park HJ, Kusnadi A et al (2012) Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors. Cell Immunol 278(1-2):76-83
148. Patterson SJ, Han JM et al (2011) Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells. J Immunol 186(10):5533-5537
149. Patton DT, Garden OA et al (2006) Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 177 (10):6598-6602
150. Peters JH, Preijers FW et al (2008) Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation. PLoS ONE 3(9): e3161
151. Putnam AL, Vendrame F et al (2005) CD4+CD25 high regulatory T cells in human autoimmune diabetes. J Autoimmun 24(1):55-62
152. Qiao YQ, Huang ML et al (2013) LncRNA DQ786243 affects Treg related CREB and Foxp3 expression in Crohn’s disease. J Biomed Sci 20:87
153. Qin J, Li R et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59-65
154. Racke MK, Burnett D et al (1995) Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 154(1):450-458
155. Rao S, Gerondakis S et al (2003) c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J Immunol 170(7):3724-3731
156. Read S, Greenwald R et al (2006) Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J Immunol 177(7):4376-4383
157. Ronchetti S, Zollo O et al (2004) GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 34(3):613-622
158. Rouas R, Fayyad-Kazan H et al (2009) Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol 39(6):1608-1618
159. Ruan Q, Kameswaran V et al (2009) Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity 31(6):932-940
160. Rubtsov YP, Rasmussen JP et al (2008) Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28(4):546-558
161. Rudra D, deRoos P et al (2012) Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat Immunol 13(10):1010-1019
162. Sadlack B, Kuhn R et al (1994) Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur J Immunol 24(1):281-284
163. Sadlack B, Lohler J et al (1995) Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol 25(11):3053-3059
164. Salomon B, Lenschow DJ et al (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12(4):431-440
165. Samstein RM, Arvey A et al (2012) Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151(1):153-166
166. Samstein RM, Josefowicz SZ et al (2012) Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150(1):29-38
167. Saoudi A, Seddon B et al (1996) The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset. Immunol Rev 149:195-216
168. Sather BD, Treuting P et al (2007) Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J Exp Med 204(6):1335-1347
169. Sattui S, de la Flor C et al (2012) Cryopreservation modulates the detection of regulatory T cell markers. Cytometry B Clin Cytom 82(1):54-58
170. Savage PA, Malchow S et al (2013) Basic principles of tumor-associated regulatory T cell biology. Trends Immunol 34(1):33-40
171. Scalapino KJ, Tang Q et al (2006) Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 177(3):1451-1459
172. Schmidl C, Klug M et al (2009) Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res 19(7):1165-1174
173. Schmidt AM, Zou T et al (2013) Diacylglycerol kinase zeta limits the generation of natural regulatory T cells. Sci Signal 6(303):ra101
174. Schmidt-Supprian M, Courtois G et al (2003) Mature T cells depend on signaling through the IKK complex. Immunity 19(3):377-389
175. Seale AC, de Jong BC et al (2008) Effects of cryopreservation on CD4+CD25+ T cells of HIV-1 infected individuals. J Clin Lab Anal 22(3):153-158
176. Sell K, Barth PJ et al (2012) Localization of FOXP3-positive cells in renal cell carcinoma. Tumour Biol 33(2):507-513
177. Shevach EM, Stephens GL (2006) The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 6(8):613-618
178. Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113(6):685-700
179. Shimizu J, Yamazaki S et al (2002) Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3(2):135-142
180. Siggs OM, Miosge LA et al (2007) Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity 27(6):912-926
181. Sledzinska A, Hemmers S et al (2013) TGF-beta Signalling Is Required for CD4(+) T Cell Homeostasis But Dispensable for Regulatory T Cell Function. PLoS Biol 11(10):e1001674
182. Sobel ES, Brusko TM et al (2011) Defective response of CD4(+) T cells to retinoic acid and TGFbeta in systemic lupus erythematosus. Arthritis Res Ther 13(3):R106
183. Somerset DA, Zheng Y et al (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25+CD4+ regulatory T-cell subset. Immunology 112(1): 38-43
184. Stephens GL, McHugh RS et al (2004) Engagement of glucocorticoid-induced TNFR familyrelated receptor on effector T cells by its ligand mediates resistance to suppression by CD4 +CD25+ T cells. J Immunol 173(8):5008-5020
185. Suen JL, Li HT et al (2009) Altered homeostasis of CD4(+)FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology 127(2):196-205
186. Suffia IJ, Reckling SK et al (2006) Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med 203(3):777-788
187. Szymczak-Workman AL, Delgoffe GM et al (2011) Cutting edge: regulatory T cells do not mediate suppression via programmed cell death pathways. J Immunol 187(9):4416-4420
188. Tai X, Cowan M et al (2005) CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 6(2):152-162
189. Takahashi T, Tagami T et al (2000) Immunologic self-tolerance maintained by CD25(+)CD4 (+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192(2):303-310
190. Tanchot C, Terme M et al (2013) Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance. Cancer Microenviron 6(2):147-157
191. Teles A, Schumacher A et al (2013) Control of uterine microenvironment by foxp3(+) cells facilitates embryo implantation. Front Immunol 4:158
192. Tivol EA, Borriello F et al (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3(5):541-547
193. Tran DQ, Ramsey H et al (2007) Induction of FOXP3 expression in naive human CD4 +FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110(8):2983-2990
194. Trzonkowski P, Bieniaszewska M et al (2009) First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells. Clin Immunol 133(1):22-26
195. Turner M, Galloway A et al (2014) Noncoding RNA and its associated proteins as regulatory elements of the immune system. Nat Immunol 15(6):484-491
196. Valencia X, Yarboro C et al (2007) Deficient CD4+CD25 high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 178(4):2579-2588
197. Valzasina B, Piconese S et al (2006) Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25− lymphocytes is thymus and proliferation independent. Cancer Res 66(8):4488-4495
198. van Santen HM, Benoist C et al (2004) Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med 200 (10):1221-1230
199. Vargas-Rojas MI, Crispin JC et al (2008) Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus 17(4):289-294
200. Venigalla RK, Tretter T et al (2008) Reduced CD4+,CD25− T cell sensitivity to the suppressive function of CD4+,CD25 high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 58(7):2120-2130
201. Viguier M, Lemaitre F et al (2004) Foxp3 expressing CD4+CD25 (high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173(2):1444-1453
202. Wainwright DA, Dey M et al (2013) Targeting tregs in malignant brain cancer: overcoming IDO. Front Immunol 4:116
203. Wan YY, Flavell RA (2005) Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci USA 102(14):5126-5131
204. Wan YY, Chi H et al (2006) The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat Immunol 7(8):851-858
205. Wang J, Huizinga TW et al (2009) De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid. J Immunol 183(6):4119-4126
206. Wang KC, Yang YW et al (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472(7341):120-124
207. Wei G, Wei L et al (2009) Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30(1): 155-167
208. Weiss JM, Bilate AM et al (2012) Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J Exp Med 209 (10):1723-1742, S1721
209. Whiteside TL (2012) What are regulatory T cells (Treg) regulating in cancer and why? Semin Cancer Biol 22(4):327-334
210. Wildin RS, Freitas A (2005) IPEX and FOXP3: clinical and research perspectives. J Autoimmun 25(Suppl):56-62
211. Wildin RS, Ramsdell F et al (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27(1):18-20
212. Wing K, Onishi Y et al (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322(5899):271-275
213. Wong J, Obst R et al (2007) Adaptation of TCR repertoires to self-peptides in regulatory and nonregulatory CD4+ T cells. J Immunol 178(11):7032-7041
214. Xufre C, Costa M et al (2013) Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients. Int Immunol 25(10):563-574
215. Yadav M, Louvet C et al (2012) Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med 209(10):1713-1722, S1711-1719
216. Yadav M, Stephan S et al (2013) Peripherally induced tregs—role in immune homeostasis and autoimmunity. Front Immunol 4:232
217. Yan B, Ye S et al (2008) Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum 58(3):801-812
218. Yang W, Xu Y (2013) Clinical significance of Treg cell frequency in acute myeloid leukemia. Int J Hematol 98(5):558-562
219. Yang ZZ, Novak AJ et al (2006) Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107 (9):3639-3646
220. Yates J, Whittington A et al (2008) Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol 153(1):44-55
221. Zhan Y, Funda DP et al (2004) TCR-mediated activation promotes GITR upregulation in T cells and resistance to glucocorticoid-induced death. Int Immunol 16(9):1315-1321
222. Zhao SS, Li XM et al (2008) Expression of CD4+CD25+CD127(low/-) T cells in patients with systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi 88(7):453-456
223. Zheng SG, Gray JD et al (2002) Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25− precursors. J Immunol 169(8):4183-4189
224. Zheng SG, Wang JH et al (2006) TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J Immunol 176(6): 3321-3329
225. Zheng SG, Wang J et al (2007) IL-2 is essential for TGF-beta to convert naive CD4+CD25− cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 178(4): 2018-2027
226. Zheng Y, Josefowicz SZ et al (2007) Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445(7130):936-940
227. Zheng Y, Chaudhry A et al (2009) Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458(7236):351-356
228. Zheng Y, Josefowicz S et al (2010) Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463(7282):808-812
229. Zhou G, Levitsky HI (2007) Natural regulatory T-cells and de novo-induced regulatory T-cells contribute independently to tumor-specific tolerance. J Immunol 178(4):2155-2162
230. Zhou X, Bailey-Bucktrout SL et al (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T-cells in vivo. Nat Immunol 10(9):1000-1007
231. Zunino SJ, Storms DH et al (2007) Diets rich in polyphenols and vitamin A inhibit the development of type I autoimmune diabetes in nonobese diabetic mice. J Nutr 137(5): 1216-1221